Robert Hershberg

Director · 3 filings · Latest: Jun 17, 2026

Adaptive Biotechnologies Corp

AtaiBeckley Inc.

RECURSION PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ADPT	ROBERT M HERSHBERG	—	Dec 10, 2025	Proposed Sale	$16.00	22,968	$367.5K	—	Dec 10 9:03 PM
ADPT	HERSHBERG ROBERT	—	Mar 12, 2025	Proposed Sale	$7.59	53,000	$402.3K	—	Mar 12 9:30 PM